A Comparative Study of Inhaled Ciclesonide Versus Placebo in Children (6-11 Years) With Asthma
Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the efficacy of inhaled ciclesonide at three
different dose levels compared with placebo with respect to pulmonary function, asthma
symptoms, and use of rescue medication in children aged 6-11 years with asthma. Treatment
medication will be administered as follows: ciclesonide or placebo will be inhaled once daily
in the evening. The study consists of a baseline period (2 to 4 weeks) and a treatment period
(12 weeks). The study provides further data on safety and tolerability of ciclesonide.